CNS Pharmaceuticals, Inc. Common Stock (CNSP) Stock Price, Quote & AI Analysis
Live CNSP stock price, real-time charts, AI-powered analysis, technical analysis, earnings insights, and market sentiment for CNS Pharmaceuticals, Inc. Common Stock.
TradeVae provides AI-driven analysis and real-time market intelligence for CNS Pharmaceuticals, Inc. Common Stock (CNSP), including price action, technical indicators, earnings performance, analyst sentiment, and risk-aware market context.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
CNS Pharmaceuticals, Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
CNS Pharmaceuticals, Inc. Common Stock Overview
Company information
Company Overview
CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12. The company was founded by Waldemar Priebe in July 2017 and is headquartered in Houston, TX.
Company Details
Technical Indicators
Key technical analysis metrics and indicators
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
CNS Pharmaceuticals, Inc. Common Stock Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...